These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13383105)

  • 41. Characterization of a plasma-derived double-viral-inactivated factor VIII concentrate (antihaemophilic factor [human]): Focus on TTP treatment.
    Mori F; Nardini I; Caricasole A; Amega NS; Farina C
    Haemophilia; 2021 May; 27(3):e409-e411. PubMed ID: 33529361
    [No Abstract]   [Full Text] [Related]  

  • 42. Factor VIII physiology and pathology in man.
    Koutts J; Howard MA; Firkin BG
    Prog Hematol; 1979; 11():115-45. PubMed ID: 392590
    [No Abstract]   [Full Text] [Related]  

  • 43. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
    Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for anthemophilic factor.
    BRECKENRIDGE RT; RATNOFF CD
    Blood; 1962 Aug; 20():137-49. PubMed ID: 13872719
    [No Abstract]   [Full Text] [Related]  

  • 45. [The factor VIII complex: hemophilia A and von Willebrand disease (author's transl)].
    Tobelem G; Rothschild C
    Ann Pediatr (Paris); 1982 Feb; 29(2):95-9. PubMed ID: 6800297
    [No Abstract]   [Full Text] [Related]  

  • 46. [Normal and abnormal values of antihemophilic globulin (AHG): interpretation of the test results].
    Matsuoka M; Toida K
    Nihon Rinsho; 1969 Mar; ():Suppl:991-9. PubMed ID: 4948306
    [No Abstract]   [Full Text] [Related]  

  • 47. [Activation of antihemophilic globulin A (factor VIII). 1. Activation by ampholine].
    Liebe S; Thierbach B
    Z Gesamte Inn Med; 1982 Feb; 37(4):105-10. PubMed ID: 6805143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
    SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
    Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
    [No Abstract]   [Full Text] [Related]  

  • 49. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

  • 50. Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A.
    HJORT PF; EGEBERG O; MIKKELSEN S
    Scand J Clin Lab Invest; 1961; 13():668-72. PubMed ID: 13907816
    [No Abstract]   [Full Text] [Related]  

  • 51. [Does lyophilization cause the appearance of a non-specific thromboplastic activity in the blood? Study of the antihemophilic factors A and B].
    DUCOS J; BIERME R
    C R Seances Soc Biol Fil; 1960; 154():808-12. PubMed ID: 13724735
    [No Abstract]   [Full Text] [Related]  

  • 52. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 53. The influence of hydergine on the coagulation time in hemophilia.
    SIMONOVIC I
    Acta Haematol; 1955 Aug; 14(2):96-9. PubMed ID: 13258141
    [No Abstract]   [Full Text] [Related]  

  • 54. [Factor VIII in hemophilia and von Willebrand's disease].
    Bolland J; Lambotte C
    Rev Med Liege; 1978 Apr; 33(8):284-95. PubMed ID: 349657
    [No Abstract]   [Full Text] [Related]  

  • 55. THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.
    BIGGS R; DENSON KW
    Br J Haematol; 1963 Oct; 9():532-47. PubMed ID: 14076135
    [No Abstract]   [Full Text] [Related]  

  • 56. Selected procoagulants in the guinea pig.
    Hurt JP; Krigman MR
    Am J Physiol; 1970 Mar; 218(3):832-7. PubMed ID: 5414044
    [No Abstract]   [Full Text] [Related]  

  • 57. On demonstration of the haemophilic conductor, especially by determination of the coagulation time.
    SJØLIN KE
    Acta Pathol Microbiol Scand; 1954; 35(6):512-22. PubMed ID: 13228064
    [No Abstract]   [Full Text] [Related]  

  • 58. Von Willebrand factor and platelet adhesiveness.
    Meyer D; Larrieu MJ
    J Clin Pathol; 1970 Apr; 23(3):228-31. PubMed ID: 5310275
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bleeding time after aspirin in disorders of intrinsic clotting.
    Kaneshiro MM; Mielke CH; Kasper CK; Rapaport SI
    N Engl J Med; 1969 Nov; 281(19):1039-42. PubMed ID: 5307310
    [No Abstract]   [Full Text] [Related]  

  • 60. [Inactive factor VIII in hemophilia A and Willebrand's disease].
    Lechner K
    Verh Dtsch Ges Inn Med; 1972; 78():710-3. PubMed ID: 4541862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.